Original Source(s)
Related Content
Tenecteplase Fails to Boost EVT Outcomes
Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.
May 14, 2026
-
6 min
Grill Brush Bristle Injuries Continue to Rise
Most patients were treated and released, with the oropharynx the most common injury site
April 10, 2026
-
3 min
Lactate–Albumin Ratio Tied to TBI Mortality
Admission biomarker showed prognostic value alongside clinical scoring systems in pediatric intensive care
April 17, 2026
-
3 min
